These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25170231)

  • 1. Efficacy of tandospirone in patients with irritable bowel syndrome-diarrhea and anxiety.
    Lan L; Chen YL; Zhang H; Jia BL; Chu YJ; Wang J; Tang SX; Xia GD
    World J Gastroenterol; 2014 Aug; 20(32):11422-8. PubMed ID: 25170231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
    Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y
    J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical evaluation of the efficacy and safety of tandospirone versus sertraline monotherapy for social anxiety disorder: a randomized open-label trial.
    Huang X; Li C; Li WH; Luo YL; Wang B; Zhang W; Gan JJ; Ji JL
    Hum Psychopharmacol; 2013 Nov; 28(6):594-9. PubMed ID: 24519693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and safety of tandospirone in the treatment of patients with anxiety disorder].
    Tao M; Han YJ; Gao JF; Tang WX; Zhu XZ; Tao DH; Zhang P; Zou Y; Chen H; Tao SF
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(13):920-3. PubMed ID: 22781535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tandospirone augmentation in major depressive disorder patients with high anxiety: A multicenter, randomized, parallel-controlled, open-label study.
    Lin J; Su Y; Wang C; Yang F; Xu Y; Yuan Y; Yuan Y; Wang X; Yu X; Si T
    J Psychiatr Res; 2018 Apr; 99():104-110. PubMed ID: 29433063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
    Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
    Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D): study protocol for a randomised controlled trial.
    Leighton MP; Lam C; Mehta S; Spiller RC
    Trials; 2013 Jan; 14():10. PubMed ID: 23302220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea.
    Lembo A; Rao SSC; Heimanson Z; Pimentel M
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00144. PubMed ID: 32352714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome.
    Saito YA; Almazar AE; Tilkes KE; Choung RS; Van Norstrand MD; Schleck CD; Zinsmeister AR; Talley NJ
    Aliment Pharmacol Ther; 2019 Feb; 49(4):389-397. PubMed ID: 30663077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pinaverium Reduces Symptoms of Irritable Bowel Syndrome in a Multicenter, Randomized, Controlled Trial.
    Zheng L; Lai Y; Lu W; Li B; Fan H; Yan Z; Gong C; Wan X; Wu J; Huang D; Wang Y; Mei Y; Li Z; Jiang Z; Liu X; Ye J; Yang Y; Huang H; Xiao J
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1285-1292.e1. PubMed ID: 25632806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
    Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
    Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome.
    Nee J; Salley K; Ludwig AG; Sommers T; Ballou S; Takazawa E; Duehren S; Singh P; Iturrino J; Katon J; Lee HN; Rangan V; Lembo AJ
    Clin Transl Gastroenterol; 2019 Dec; 10(12):e00110. PubMed ID: 31800542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
    Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
    Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
    Chang FY; Lu CL; Chen CY; Luo JC
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of tandospirone augmentation in patients with major depressive disorder: a randomized controlled trial.
    Yamada K; Yagi G; Kanba S
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):183-7. PubMed ID: 12667165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial.
    Di Nardo G; Bernardo L; Cremon C; Barbara G; Felici E; Evangelisti M; Ferretti A; Furio S; Piccirillo M; Coluzzi F; Parisi P; Mauro A; Di Mari C; D'Angelo F; Mennini M
    Nutrition; 2024 Jun; 122():112397. PubMed ID: 38479039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
    Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
    J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Chen C; Tao C; Liu Z; Lu M; Pan Q; Zheng L; Li Q; Song Z; Fichna J
    Phytother Res; 2015 Nov; 29(11):1822-7. PubMed ID: 26400188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effect of abdominal acupuncture for diarrhea irritable bowel syndrome].
    Qin Y; Yi W; Lin S; Yang C; Zhuang Z
    Zhongguo Zhen Jiu; 2017 Dec; 37(12):1265-8. PubMed ID: 29354989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.